Num | GO | Overlap | Size | P Value | Adj. P Value |
1 |
REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT |
254 |
1672 |
5.138e-42 |
2.391e-38 |
2 |
BIOLOGICAL ADHESION |
182 |
1032 |
2.955e-38 |
6.876e-35 |
3 |
REGULATION OF CELLULAR COMPONENT MOVEMENT |
146 |
771 |
4.26e-34 |
6.607e-31 |
4 |
REGULATION OF CELL DIFFERENTIATION |
218 |
1492 |
3.841e-33 |
4.468e-30 |
5 |
POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
203 |
1395 |
1.605e-30 |
1.244e-27 |
6 |
CELL DEVELOPMENT |
206 |
1426 |
1.514e-30 |
1.244e-27 |
7 |
REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS |
164 |
1021 |
1.899e-29 |
1.263e-26 |
8 |
NEUROGENESIS |
201 |
1402 |
2.486e-29 |
1.446e-26 |
9 |
POSITIVE REGULATION OF DEVELOPMENTAL PROCESS |
175 |
1142 |
6.564e-29 |
3.393e-26 |
10 |
REGULATION OF CELL PROLIFERATION |
206 |
1496 |
1.059e-27 |
4.928e-25 |
11 |
CARDIOVASCULAR SYSTEM DEVELOPMENT |
136 |
788 |
1.554e-27 |
6.027e-25 |
12 |
CIRCULATORY SYSTEM DEVELOPMENT |
136 |
788 |
1.554e-27 |
6.027e-25 |
13 |
MOVEMENT OF CELL OR SUBCELLULAR COMPONENT |
184 |
1275 |
3.888e-27 |
1.392e-24 |
14 |
VASCULATURE DEVELOPMENT |
99 |
469 |
4.771e-27 |
1.586e-24 |
15 |
LOCOMOTION |
168 |
1114 |
6.309e-27 |
1.957e-24 |
16 |
TISSUE DEVELOPMENT |
206 |
1518 |
7.408e-27 |
2.154e-24 |
17 |
POSITIVE REGULATION OF RESPONSE TO STIMULUS |
242 |
1929 |
1.292e-26 |
3.537e-24 |
18 |
CELLULAR RESPONSE TO ORGANIC SUBSTANCE |
233 |
1848 |
7.089e-26 |
1.832e-23 |
19 |
REGULATION OF CELL DEVELOPMENT |
137 |
836 |
1.836e-25 |
4.496e-23 |
20 |
BLOOD VESSEL MORPHOGENESIS |
83 |
364 |
3.482e-25 |
8.101e-23 |
21 |
REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
212 |
1656 |
2.68e-24 |
5.938e-22 |
22 |
CELL CELL ADHESION |
108 |
608 |
5.431e-23 |
1.149e-20 |
23 |
POSITIVE REGULATION OF CELL DIFFERENTIATION |
130 |
823 |
1.073e-22 |
2.17e-20 |
24 |
REGULATION OF NEURON DIFFERENTIATION |
101 |
554 |
2.007e-22 |
3.891e-20 |
25 |
NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
145 |
983 |
2.702e-22 |
5.028e-20 |
26 |
EXTRACELLULAR STRUCTURE ORGANIZATION |
70 |
304 |
1.142e-21 |
2.044e-19 |
27 |
CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
95 |
513 |
1.212e-21 |
2.089e-19 |
28 |
POSITIVE REGULATION OF CELL COMMUNICATION |
193 |
1532 |
2.969e-21 |
4.934e-19 |
29 |
RESPONSE TO ENDOGENOUS STIMULUS |
184 |
1450 |
1.342e-20 |
2.153e-18 |
30 |
NEURON DIFFERENTIATION |
130 |
874 |
2.373e-20 |
3.68e-18 |
31 |
POSITIVE REGULATION OF CELL PROLIFERATION |
124 |
814 |
2.579e-20 |
3.871e-18 |
32 |
REGULATION OF CELL ADHESION |
105 |
629 |
2.863e-20 |
4.163e-18 |
33 |
RESPONSE TO EXTERNAL STIMULUS |
215 |
1821 |
3.3e-20 |
4.653e-18 |
34 |
CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND |
121 |
799 |
1.256e-19 |
1.669e-17 |
35 |
REGULATION OF PHOSPHORUS METABOLIC PROCESS |
196 |
1618 |
1.246e-19 |
1.669e-17 |
36 |
ANGIOGENESIS |
65 |
293 |
2.648e-19 |
3.422e-17 |
37 |
RESPONSE TO WOUNDING |
96 |
563 |
2.935e-19 |
3.69e-17 |
38 |
RESPONSE TO OXYGEN CONTAINING COMPOUND |
174 |
1381 |
3.72e-19 |
4.556e-17 |
39 |
REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
115 |
750 |
4.074e-19 |
4.861e-17 |
40 |
POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
142 |
1036 |
7.056e-19 |
8.008e-17 |
41 |
POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
142 |
1036 |
7.056e-19 |
8.008e-17 |
42 |
NEGATIVE REGULATION OF CELL PROLIFERATION |
103 |
643 |
1.416e-18 |
1.569e-16 |
43 |
CELL MOTILITY |
122 |
835 |
1.668e-18 |
1.764e-16 |
44 |
LOCALIZATION OF CELL |
122 |
835 |
1.668e-18 |
1.764e-16 |
45 |
MUSCLE STRUCTURE DEVELOPMENT |
80 |
432 |
2.174e-18 |
2.199e-16 |
46 |
CELLULAR COMPONENT MORPHOGENESIS |
128 |
900 |
2.151e-18 |
2.199e-16 |
47 |
NEGATIVE REGULATION OF RESPONSE TO STIMULUS |
170 |
1360 |
2.262e-18 |
2.239e-16 |
48 |
CELLULAR RESPONSE TO ENDOGENOUS STIMULUS |
138 |
1008 |
2.573e-18 |
2.494e-16 |
49 |
ORGAN MORPHOGENESIS |
122 |
841 |
2.977e-18 |
2.827e-16 |
50 |
POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
125 |
876 |
4.27e-18 |
3.974e-16 |
51 |
NEGATIVE REGULATION OF CELL COMMUNICATION |
154 |
1192 |
5.501e-18 |
5.019e-16 |
52 |
ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS |
132 |
957 |
8.111e-18 |
7.258e-16 |
53 |
NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS |
117 |
801 |
9.098e-18 |
7.987e-16 |
54 |
TAXIS |
82 |
464 |
1.497e-17 |
1.29e-15 |
55 |
REGULATION OF NEURON PROJECTION DEVELOPMENT |
75 |
408 |
3.979e-17 |
3.366e-15 |
56 |
POSITIVE REGULATION OF CELL DEVELOPMENT |
82 |
472 |
4.269e-17 |
3.547e-15 |
57 |
REGULATION OF CELL PROJECTION ORGANIZATION |
91 |
558 |
4.971e-17 |
4.058e-15 |
58 |
CELL ACTIVATION |
92 |
568 |
5.194e-17 |
4.167e-15 |
59 |
POSITIVE REGULATION OF LOCOMOTION |
75 |
420 |
2.086e-16 |
1.645e-14 |
60 |
NEURON PROJECTION DEVELOPMENT |
88 |
545 |
3.113e-16 |
2.414e-14 |
61 |
SINGLE ORGANISM CELL ADHESION |
78 |
459 |
9.122e-16 |
6.958e-14 |
62 |
NEURON DEVELOPMENT |
101 |
687 |
1.192e-15 |
8.944e-14 |
63 |
REGULATION OF PROTEIN MODIFICATION PROCESS |
191 |
1710 |
1.993e-15 |
1.472e-13 |
64 |
HEART DEVELOPMENT |
78 |
466 |
2.157e-15 |
1.548e-13 |
65 |
CENTRAL NERVOUS SYSTEM DEVELOPMENT |
118 |
872 |
2.162e-15 |
1.548e-13 |
66 |
NEURON PROJECTION MORPHOGENESIS |
71 |
402 |
2.428e-15 |
1.712e-13 |
67 |
POSITIVE REGULATION OF NEURON DIFFERENTIATION |
60 |
306 |
2.881e-15 |
2.001e-13 |
68 |
POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS |
172 |
1492 |
3.583e-15 |
2.452e-13 |
69 |
WOUND HEALING |
77 |
470 |
1.078e-14 |
7.269e-13 |
70 |
CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION |
66 |
368 |
1.112e-14 |
7.393e-13 |
71 |
INTRACELLULAR SIGNAL TRANSDUCTION |
177 |
1572 |
1.228e-14 |
8.048e-13 |
72 |
SKELETAL SYSTEM DEVELOPMENT |
75 |
455 |
1.738e-14 |
1.123e-12 |
73 |
IMMUNE SYSTEM PROCESS |
210 |
1984 |
1.84e-14 |
1.173e-12 |
74 |
POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
73 |
437 |
1.946e-14 |
1.223e-12 |
75 |
POSITIVE REGULATION OF MOLECULAR FUNCTION |
193 |
1791 |
4.788e-14 |
2.942e-12 |
76 |
REGULATION OF CELL MORPHOGENESIS |
84 |
552 |
4.806e-14 |
2.942e-12 |
77 |
MUSCLE SYSTEM PROCESS |
55 |
282 |
5.287e-14 |
3.195e-12 |
78 |
CELL PROJECTION ORGANIZATION |
117 |
902 |
5.93e-14 |
3.537e-12 |
79 |
CONNECTIVE TISSUE DEVELOPMENT |
44 |
194 |
7.416e-14 |
4.368e-12 |
80 |
REGULATION OF CELL DEATH |
166 |
1472 |
8.193e-14 |
4.765e-12 |
81 |
REGULATION OF MAPK CASCADE |
94 |
660 |
8.655e-14 |
4.972e-12 |
82 |
POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
137 |
1135 |
1.042e-13 |
5.912e-12 |
83 |
REGULATION OF TRANSPORT |
192 |
1804 |
1.846e-13 |
1.035e-11 |
84 |
RESPONSE TO ORGANIC CYCLIC COMPOUND |
117 |
917 |
1.869e-13 |
1.035e-11 |
85 |
BEHAVIOR |
79 |
516 |
2.021e-13 |
1.106e-11 |
86 |
NEGATIVE REGULATION OF CELL DIFFERENTIATION |
88 |
609 |
2.434e-13 |
1.317e-11 |
87 |
CIRCULATORY SYSTEM PROCESS |
63 |
366 |
3.12e-13 |
1.669e-11 |
88 |
NEGATIVE REGULATION OF LOCOMOTION |
51 |
263 |
5.554e-13 |
2.937e-11 |
89 |
REGULATION OF HOMEOSTATIC PROCESS |
71 |
447 |
5.708e-13 |
2.984e-11 |
90 |
POSITIVE REGULATION OF CELL ADHESION |
63 |
376 |
1.079e-12 |
5.578e-11 |
91 |
POSITIVE REGULATION OF CATALYTIC ACTIVITY |
166 |
1518 |
1.137e-12 |
5.814e-11 |
92 |
RESPONSE TO LIPID |
112 |
888 |
1.362e-12 |
6.89e-11 |
93 |
POSITIVE REGULATION OF GENE EXPRESSION |
183 |
1733 |
1.533e-12 |
7.587e-11 |
94 |
RESPONSE TO CYTOKINE |
96 |
714 |
1.527e-12 |
7.587e-11 |
95 |
TISSUE MORPHOGENESIS |
78 |
533 |
3.058e-12 |
1.498e-10 |
96 |
REGULATION OF VASCULATURE DEVELOPMENT |
46 |
233 |
3.969e-12 |
1.924e-10 |
97 |
RESPONSE TO HORMONE |
111 |
893 |
4.409e-12 |
2.115e-10 |
98 |
POSITIVE REGULATION OF HYDROLASE ACTIVITY |
112 |
905 |
4.642e-12 |
2.204e-10 |
99 |
GROWTH |
65 |
410 |
6.048e-12 |
2.814e-10 |
100 |
REGULATION OF ION TRANSPORT |
83 |
592 |
6.018e-12 |
2.814e-10 |
101 |
REGULATION OF IMMUNE SYSTEM PROCESS |
154 |
1403 |
6.288e-12 |
2.897e-10 |
102 |
POSITIVE REGULATION OF VASCULATURE DEVELOPMENT |
33 |
133 |
7.186e-12 |
3.278e-10 |
103 |
CELL CELL SIGNALING |
99 |
767 |
7.74e-12 |
3.496e-10 |
104 |
REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
57 |
337 |
8.842e-12 |
3.956e-10 |
105 |
LEUKOCYTE ACTIVATION |
65 |
414 |
9.379e-12 |
4.156e-10 |
106 |
NEURON PROJECTION GUIDANCE |
42 |
205 |
9.727e-12 |
4.27e-10 |
107 |
MESENCHYME DEVELOPMENT |
40 |
190 |
1.239e-11 |
5.389e-10 |
108 |
REGULATION OF SYSTEM PROCESS |
74 |
507 |
1.274e-11 |
5.458e-10 |
109 |
POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT |
45 |
232 |
1.279e-11 |
5.458e-10 |
110 |
POSITIVE REGULATION OF BIOSYNTHETIC PROCESS |
185 |
1805 |
1.557e-11 |
6.585e-10 |
111 |
REGULATION OF METAL ION TRANSPORT |
55 |
325 |
2.011e-11 |
8.43e-10 |
112 |
MUSCLE CELL DIFFERENTIATION |
45 |
237 |
2.717e-11 |
1.129e-09 |
113 |
CELLULAR RESPONSE TO NITROGEN COMPOUND |
73 |
505 |
2.788e-11 |
1.148e-09 |
114 |
RESPONSE TO GROWTH FACTOR |
70 |
475 |
2.962e-11 |
1.209e-09 |
115 |
EPITHELIUM DEVELOPMENT |
113 |
945 |
3.275e-11 |
1.321e-09 |
116 |
LEUKOCYTE DIFFERENTIATION |
51 |
292 |
3.321e-11 |
1.321e-09 |
117 |
HEAD DEVELOPMENT |
92 |
709 |
3.306e-11 |
1.321e-09 |
118 |
IMMUNE SYSTEM DEVELOPMENT |
80 |
582 |
3.992e-11 |
1.574e-09 |
119 |
POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION |
52 |
303 |
4.181e-11 |
1.635e-09 |
120 |
REGULATION OF EPITHELIAL CELL PROLIFERATION |
50 |
285 |
4.386e-11 |
1.701e-09 |
121 |
DEVELOPMENTAL GROWTH |
55 |
333 |
5.286e-11 |
2.033e-09 |
122 |
MORPHOGENESIS OF A BRANCHING STRUCTURE |
36 |
167 |
6.443e-11 |
2.457e-09 |
123 |
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
117 |
1004 |
7.368e-11 |
2.787e-09 |
124 |
NEPHRON DEVELOPMENT |
29 |
115 |
8.743e-11 |
3.281e-09 |
125 |
HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES |
34 |
153 |
9.11e-11 |
3.391e-09 |
126 |
RESPONSE TO NITROGEN COMPOUND |
104 |
859 |
1.027e-10 |
3.793e-09 |
127 |
MUSCLE TISSUE DEVELOPMENT |
48 |
275 |
1.288e-10 |
4.717e-09 |
128 |
POSITIVE REGULATION OF MAPK CASCADE |
68 |
470 |
1.298e-10 |
4.719e-09 |
129 |
REGULATION OF CELL CELL ADHESION |
59 |
380 |
1.357e-10 |
4.894e-09 |
130 |
LYMPHOCYTE ACTIVATION |
55 |
342 |
1.498e-10 |
5.363e-09 |
131 |
MUSCLE ORGAN DEVELOPMENT |
48 |
277 |
1.666e-10 |
5.917e-09 |
132 |
SINGLE ORGANISM BEHAVIOR |
59 |
384 |
2.071e-10 |
7.3e-09 |
133 |
REGULATION OF DEVELOPMENTAL GROWTH |
49 |
289 |
2.354e-10 |
8.236e-09 |
134 |
CELLULAR RESPONSE TO LIPID |
66 |
457 |
2.635e-10 |
9.15e-09 |
135 |
POSITIVE REGULATION OF CELL DEATH |
80 |
605 |
2.692e-10 |
9.278e-09 |
136 |
CHEMICAL HOMEOSTASIS |
104 |
874 |
2.777e-10 |
9.431e-09 |
137 |
REGULATION OF HYDROLASE ACTIVITY |
142 |
1327 |
2.771e-10 |
9.431e-09 |
138 |
REGULATION OF GTPASE ACTIVITY |
86 |
673 |
3.243e-10 |
1.094e-08 |
139 |
LEUKOCYTE CELL CELL ADHESION |
45 |
255 |
3.368e-10 |
1.127e-08 |
140 |
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
178 |
1784 |
3.561e-10 |
1.184e-08 |
141 |
REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS |
42 |
229 |
3.828e-10 |
1.263e-08 |
142 |
REGULATION OF ACTIN FILAMENT BASED PROCESS |
51 |
312 |
3.878e-10 |
1.271e-08 |
143 |
HEART MORPHOGENESIS |
40 |
212 |
4.167e-10 |
1.356e-08 |
144 |
CELL PART MORPHOGENESIS |
82 |
633 |
4.388e-10 |
1.418e-08 |
145 |
CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES |
39 |
204 |
4.61e-10 |
1.479e-08 |
146 |
REGULATION OF CELL ACTIVATION |
68 |
484 |
4.696e-10 |
1.497e-08 |
147 |
REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION |
47 |
278 |
6.039e-10 |
1.911e-08 |
148 |
REGULATION OF HOMOTYPIC CELL CELL ADHESION |
50 |
307 |
6.559e-10 |
2.062e-08 |
149 |
STEM CELL DIFFERENTIATION |
37 |
190 |
7.488e-10 |
2.338e-08 |
150 |
FOREBRAIN DEVELOPMENT |
55 |
357 |
7.703e-10 |
2.389e-08 |
151 |
POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS |
102 |
867 |
7.826e-10 |
2.397e-08 |
152 |
UROGENITAL SYSTEM DEVELOPMENT |
49 |
299 |
7.829e-10 |
2.397e-08 |
153 |
POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
126 |
1152 |
8.037e-10 |
2.444e-08 |
154 |
REGULATION OF CARTILAGE DEVELOPMENT |
20 |
63 |
9.034e-10 |
2.729e-08 |
155 |
ACTIN FILAMENT BASED PROCESS |
64 |
450 |
9.309e-10 |
2.795e-08 |
156 |
LYMPHOCYTE DIFFERENTIATION |
39 |
209 |
9.614e-10 |
2.867e-08 |
157 |
ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY |
86 |
689 |
1.047e-09 |
3.102e-08 |
158 |
RESPONSE TO MECHANICAL STIMULUS |
39 |
210 |
1.11e-09 |
3.269e-08 |
159 |
REGULATION OF MEMBRANE POTENTIAL |
53 |
343 |
1.408e-09 |
4.119e-08 |
160 |
REGULATION OF BLOOD CIRCULATION |
48 |
295 |
1.487e-09 |
4.325e-08 |
161 |
CELLULAR RESPONSE TO CYTOKINE STIMULUS |
78 |
606 |
1.592e-09 |
4.579e-08 |
162 |
REGULATION OF MUSCLE SYSTEM PROCESS |
37 |
195 |
1.594e-09 |
4.579e-08 |
163 |
NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
72 |
541 |
1.624e-09 |
4.608e-08 |
164 |
NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
72 |
541 |
1.624e-09 |
4.608e-08 |
165 |
TUBE DEVELOPMENT |
73 |
552 |
1.652e-09 |
4.659e-08 |
166 |
REGULATION OF CELLULAR LOCALIZATION |
135 |
1277 |
1.764e-09 |
4.946e-08 |
167 |
CARTILAGE DEVELOPMENT |
31 |
147 |
2.38e-09 |
6.631e-08 |
168 |
CELL SUBSTRATE ADHESION |
33 |
164 |
2.588e-09 |
7.167e-08 |
169 |
REGULATION OF CALCIUM ION TRANSPORT |
38 |
209 |
3.356e-09 |
9.239e-08 |
170 |
REGULATION OF EPITHELIAL CELL MIGRATION |
33 |
166 |
3.569e-09 |
9.769e-08 |
171 |
CELLULAR RESPONSE TO HORMONE STIMULUS |
72 |
552 |
3.887e-09 |
1.055e-07 |
172 |
RESPONSE TO ABIOTIC STIMULUS |
113 |
1024 |
3.901e-09 |
1.055e-07 |
173 |
MESENCHYMAL CELL DIFFERENTIATION |
29 |
134 |
4.147e-09 |
1.115e-07 |
174 |
REGULATION OF ERK1 AND ERK2 CASCADE |
41 |
238 |
4.255e-09 |
1.138e-07 |
175 |
NEGATIVE REGULATION OF TRANSPORT |
63 |
458 |
4.78e-09 |
1.271e-07 |
176 |
DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS |
25 |
104 |
5.014e-09 |
1.326e-07 |
177 |
REGULATION OF OSSIFICATION |
34 |
178 |
6.087e-09 |
1.6e-07 |
178 |
OSSIFICATION |
42 |
251 |
6.731e-09 |
1.759e-07 |
179 |
REGULATION OF ORGAN MORPHOGENESIS |
41 |
242 |
7.02e-09 |
1.825e-07 |
180 |
REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
37 |
207 |
8.684e-09 |
2.245e-07 |
181 |
NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS |
54 |
372 |
9.399e-09 |
2.416e-07 |
182 |
REGULATION OF SECRETION |
84 |
699 |
9.874e-09 |
2.511e-07 |
183 |
SYSTEM PROCESS |
172 |
1785 |
9.85e-09 |
2.511e-07 |
184 |
BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE |
28 |
131 |
1.024e-08 |
2.588e-07 |
185 |
STRIATED MUSCLE CELL DIFFERENTIATION |
33 |
173 |
1.051e-08 |
2.629e-07 |
186 |
REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION |
24 |
100 |
1.048e-08 |
2.629e-07 |
187 |
TUBE MORPHOGENESIS |
49 |
323 |
1.082e-08 |
2.692e-07 |
188 |
CELL FATE COMMITMENT |
39 |
227 |
1.092e-08 |
2.703e-07 |
189 |
REGULATION OF TRANSMEMBRANE TRANSPORT |
59 |
426 |
1.146e-08 |
2.822e-07 |
190 |
POSITIVE REGULATION OF TRANSPORT |
104 |
936 |
1.182e-08 |
2.894e-07 |
191 |
REGULATION OF ANATOMICAL STRUCTURE SIZE |
63 |
472 |
1.54e-08 |
3.752e-07 |
192 |
CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND |
62 |
465 |
2.086e-08 |
5.055e-07 |
193 |
CELL MATRIX ADHESION |
26 |
119 |
2.114e-08 |
5.097e-07 |
194 |
MUSCLE CONTRACTION |
39 |
233 |
2.294e-08 |
5.501e-07 |
195 |
RESPONSE TO MOLECULE OF BACTERIAL ORIGIN |
48 |
321 |
2.428e-08 |
5.794e-07 |
196 |
REGULATION OF GROWTH |
77 |
633 |
2.462e-08 |
5.844e-07 |
197 |
REGULATION OF LEUKOCYTE PROLIFERATION |
36 |
206 |
2.526e-08 |
5.967e-07 |
198 |
REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
102 |
926 |
2.567e-08 |
6.033e-07 |
199 |
POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION |
31 |
162 |
2.696e-08 |
6.305e-07 |
200 |
POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION |
30 |
154 |
2.95e-08 |
6.829e-07 |
201 |
AMEBOIDAL TYPE CELL MIGRATION |
30 |
154 |
2.95e-08 |
6.829e-07 |
202 |
ENDOTHELIUM DEVELOPMENT |
22 |
90 |
2.984e-08 |
6.874e-07 |
203 |
NEGATIVE REGULATION OF GROWTH |
39 |
236 |
3.285e-08 |
7.531e-07 |
204 |
TELENCEPHALON DEVELOPMENT |
38 |
228 |
3.894e-08 |
8.882e-07 |
205 |
REGULATION OF BODY FLUID LEVELS |
65 |
506 |
4.033e-08 |
9.109e-07 |
206 |
TISSUE MIGRATION |
21 |
84 |
4.016e-08 |
9.109e-07 |
207 |
REGULATION OF ION HOMEOSTASIS |
35 |
201 |
4.321e-08 |
9.699e-07 |
208 |
T CELL DIFFERENTIATION |
26 |
123 |
4.336e-08 |
9.699e-07 |
209 |
REGULATION OF PROTEIN SECRETION |
54 |
389 |
4.417e-08 |
9.834e-07 |
210 |
REGULATION OF CYTOKINE PRODUCTION |
70 |
563 |
4.533e-08 |
1.004e-06 |
211 |
MORPHOGENESIS OF AN EPITHELIUM |
55 |
400 |
4.607e-08 |
1.016e-06 |
212 |
ENDOTHELIAL CELL MIGRATION |
17 |
57 |
4.693e-08 |
1.03e-06 |
213 |
NEGATIVE REGULATION OF PHOSPHORYLATION |
57 |
422 |
4.931e-08 |
1.077e-06 |
214 |
RENAL TUBULE DEVELOPMENT |
20 |
78 |
5.323e-08 |
1.157e-06 |
215 |
NEPHRON EPITHELIUM DEVELOPMENT |
22 |
93 |
5.643e-08 |
1.221e-06 |
216 |
CELL JUNCTION ORGANIZATION |
33 |
185 |
5.752e-08 |
1.239e-06 |
217 |
COGNITION |
40 |
251 |
6.145e-08 |
1.318e-06 |
218 |
PLATELET ACTIVATION |
28 |
142 |
6.454e-08 |
1.378e-06 |
219 |
REGULATION OF KINASE ACTIVITY |
88 |
776 |
6.61e-08 |
1.404e-06 |
220 |
SECOND MESSENGER MEDIATED SIGNALING |
30 |
160 |
7.251e-08 |
1.534e-06 |
221 |
POSITIVE REGULATION OF CELL CELL ADHESION |
39 |
243 |
7.382e-08 |
1.554e-06 |
222 |
REGULATION OF CHONDROCYTE DIFFERENTIATION |
15 |
46 |
7.669e-08 |
1.607e-06 |
223 |
POSITIVE REGULATION OF KINASE ACTIVITY |
62 |
482 |
7.903e-08 |
1.649e-06 |
224 |
CARDIAC CHAMBER DEVELOPMENT |
28 |
144 |
8.812e-08 |
1.829e-06 |
225 |
REGULATION OF HEMOPOIESIS |
46 |
314 |
8.852e-08 |
1.829e-06 |
226 |
EMBRYONIC MORPHOGENESIS |
67 |
539 |
8.909e-08 |
1.829e-06 |
227 |
NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
42 |
274 |
8.923e-08 |
1.829e-06 |
228 |
CELL CHEMOTAXIS |
30 |
162 |
9.673e-08 |
1.974e-06 |
229 |
CYTOKINE MEDIATED SIGNALING PATHWAY |
59 |
452 |
9.752e-08 |
1.981e-06 |
230 |
POSITIVE REGULATION OF ION TRANSPORT |
38 |
236 |
9.913e-08 |
2.006e-06 |
231 |
IMMUNE RESPONSE |
114 |
1100 |
1.039e-07 |
2.093e-06 |
232 |
REGULATION OF RESPONSE TO STRESS |
143 |
1468 |
1.067e-07 |
2.14e-06 |
233 |
ION HOMEOSTASIS |
70 |
576 |
1.114e-07 |
2.225e-06 |
234 |
CELL JUNCTION ASSEMBLY |
26 |
129 |
1.194e-07 |
2.375e-06 |
235 |
GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS |
11 |
25 |
1.223e-07 |
2.421e-06 |
236 |
NEGATIVE REGULATION OF CELL DEATH |
95 |
872 |
1.327e-07 |
2.616e-06 |
237 |
REGULATION OF MUSCLE CONTRACTION |
28 |
147 |
1.389e-07 |
2.726e-06 |
238 |
ARTERY DEVELOPMENT |
19 |
75 |
1.406e-07 |
2.749e-06 |
239 |
MEMBRANE DEPOLARIZATION |
17 |
61 |
1.417e-07 |
2.759e-06 |
240 |
NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION |
13 |
36 |
1.445e-07 |
2.799e-06 |
241 |
ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY |
18 |
68 |
1.45e-07 |
2.799e-06 |
242 |
REGULATION OF HEART CONTRACTION |
36 |
221 |
1.59e-07 |
3.057e-06 |
243 |
CELLULAR CHEMICAL HOMEOSTASIS |
69 |
570 |
1.596e-07 |
3.057e-06 |
244 |
HOMEOSTATIC PROCESS |
132 |
1337 |
1.631e-07 |
3.111e-06 |
245 |
NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
57 |
437 |
1.646e-07 |
3.117e-06 |
246 |
LEARNING |
26 |
131 |
1.648e-07 |
3.117e-06 |
247 |
REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION |
32 |
184 |
1.669e-07 |
3.143e-06 |
248 |
CELLULAR RESPONSE TO ACID CHEMICAL |
31 |
175 |
1.692e-07 |
3.171e-06 |
249 |
RESPONSE TO OXIDATIVE STRESS |
49 |
352 |
1.697e-07 |
3.171e-06 |
250 |
HEMOSTASIS |
45 |
311 |
1.756e-07 |
3.269e-06 |
251 |
CARDIAC MUSCLE TISSUE DEVELOPMENT |
27 |
140 |
1.775e-07 |
3.291e-06 |
252 |
SENSORY ORGAN DEVELOPMENT |
62 |
493 |
1.784e-07 |
3.294e-06 |
253 |
AMINOGLYCAN BIOSYNTHETIC PROCESS |
23 |
107 |
1.866e-07 |
3.42e-06 |
254 |
REGULATION OF LEUKOCYTE DIFFERENTIATION |
37 |
232 |
1.867e-07 |
3.42e-06 |
255 |
MULTI MULTICELLULAR ORGANISM PROCESS |
35 |
213 |
1.895e-07 |
3.458e-06 |
256 |
DIVALENT INORGANIC CATION HOMEOSTASIS |
48 |
343 |
1.927e-07 |
3.503e-06 |
257 |
NEGATIVE REGULATION OF CELL ADHESION |
36 |
223 |
2.001e-07 |
3.623e-06 |
258 |
REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL |
21 |
92 |
2.159e-07 |
3.894e-06 |
259 |
REGULATION OF AXONOGENESIS |
30 |
168 |
2.222e-07 |
3.992e-06 |
260 |
CELL PROLIFERATION |
77 |
672 |
2.951e-07 |
5.28e-06 |
261 |
CELL GROWTH |
26 |
135 |
3.069e-07 |
5.471e-06 |
262 |
REGULATION OF RESPONSE TO WOUNDING |
54 |
413 |
3.211e-07 |
5.655e-06 |
263 |
REGULATION OF PROTEIN LOCALIZATION |
100 |
950 |
3.192e-07 |
5.655e-06 |
264 |
NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
22 |
102 |
3.221e-07 |
5.655e-06 |
265 |
REGULATION OF CATION TRANSMEMBRANE TRANSPORT |
34 |
208 |
3.205e-07 |
5.655e-06 |
266 |
REGULATION OF CHEMOTAXIS |
31 |
180 |
3.241e-07 |
5.669e-06 |
267 |
POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION |
26 |
136 |
3.569e-07 |
6.22e-06 |
268 |
CELLULAR HOMEOSTASIS |
77 |
676 |
3.742e-07 |
6.496e-06 |
269 |
POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE |
30 |
172 |
3.77e-07 |
6.52e-06 |
270 |
CELLULAR RESPONSE TO BIOTIC STIMULUS |
29 |
163 |
3.814e-07 |
6.573e-06 |
271 |
REGULATION OF MUSCLE TISSUE DEVELOPMENT |
22 |
103 |
3.853e-07 |
6.616e-06 |
272 |
EMBRYO DEVELOPMENT |
95 |
894 |
4.165e-07 |
7.125e-06 |
273 |
POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION |
13 |
39 |
4.247e-07 |
7.239e-06 |
274 |
REGULATION OF CELL SUBSTRATE ADHESION |
30 |
173 |
4.289e-07 |
7.26e-06 |
275 |
SKELETAL SYSTEM MORPHOGENESIS |
33 |
201 |
4.291e-07 |
7.26e-06 |
276 |
CARDIAC CHAMBER MORPHOGENESIS |
22 |
104 |
4.598e-07 |
7.752e-06 |
277 |
CARDIOCYTE DIFFERENTIATION |
21 |
96 |
4.627e-07 |
7.773e-06 |
278 |
MODULATION OF SYNAPTIC TRANSMISSION |
43 |
301 |
4.683e-07 |
7.838e-06 |
279 |
REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING |
26 |
138 |
4.803e-07 |
8.009e-06 |
280 |
MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL |
8 |
14 |
5.371e-07 |
8.925e-06 |
281 |
GLIOGENESIS |
30 |
175 |
5.532e-07 |
9.161e-06 |
282 |
NEGATIVE REGULATION OF CELL DEVELOPMENT |
43 |
303 |
5.625e-07 |
9.281e-06 |
283 |
REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION |
34 |
213 |
5.673e-07 |
9.295e-06 |
284 |
AMINOGLYCAN METABOLIC PROCESS |
29 |
166 |
5.666e-07 |
9.295e-06 |
285 |
REGULATION OF CELLULAR COMPONENT BIOGENESIS |
84 |
767 |
5.812e-07 |
9.489e-06 |
286 |
MESONEPHRIC TUBULE MORPHOGENESIS |
15 |
53 |
6.154e-07 |
1.001e-05 |
287 |
NEGATIVE REGULATION OF CELL ACTIVATION |
28 |
158 |
6.544e-07 |
1.057e-05 |
288 |
RESPONSE TO PURINE CONTAINING COMPOUND |
28 |
158 |
6.544e-07 |
1.057e-05 |
289 |
ORGAN GROWTH |
17 |
68 |
7.779e-07 |
1.252e-05 |
290 |
REGULATION OF IMMUNE RESPONSE |
91 |
858 |
7.989e-07 |
1.282e-05 |
291 |
REGULATION OF BLOOD PRESSURE |
29 |
169 |
8.323e-07 |
1.331e-05 |
292 |
REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT |
23 |
116 |
8.546e-07 |
1.362e-05 |
293 |
MUCOPOLYSACCHARIDE METABOLIC PROCESS |
22 |
108 |
9.097e-07 |
1.445e-05 |
294 |
KIDNEY EPITHELIUM DEVELOPMENT |
24 |
125 |
9.178e-07 |
1.453e-05 |
295 |
EPITHELIAL CELL DIFFERENTIATION |
60 |
495 |
9.814e-07 |
1.548e-05 |
296 |
SECRETION |
68 |
588 |
1.053e-06 |
1.655e-05 |
297 |
DEVELOPMENTAL CELL GROWTH |
18 |
77 |
1.08e-06 |
1.693e-05 |
298 |
LEUKOCYTE MIGRATION |
38 |
259 |
1.105e-06 |
1.72e-05 |
299 |
POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
28 |
162 |
1.103e-06 |
1.72e-05 |
300 |
RESPONSE TO TRANSFORMING GROWTH FACTOR BETA |
26 |
144 |
1.125e-06 |
1.74e-05 |
301 |
PALLIUM DEVELOPMENT |
27 |
153 |
1.123e-06 |
1.74e-05 |
302 |
ACTIN FILAMENT BASED MOVEMENT |
20 |
93 |
1.15e-06 |
1.749e-05 |
303 |
POSITIVE REGULATION OF CELL ACTIVATION |
43 |
311 |
1.146e-06 |
1.749e-05 |
304 |
MULTICELLULAR ORGANISM METABOLIC PROCESS |
20 |
93 |
1.15e-06 |
1.749e-05 |
305 |
NEGATIVE REGULATION OF SECRETION |
32 |
200 |
1.147e-06 |
1.749e-05 |
306 |
HEART PROCESS |
19 |
85 |
1.138e-06 |
1.749e-05 |
307 |
NEGATIVE REGULATION OF NEURON DIFFERENTIATION |
31 |
191 |
1.226e-06 |
1.859e-05 |
308 |
REGULATION OF SMOOTH MUSCLE CELL MIGRATION |
14 |
49 |
1.283e-06 |
1.938e-05 |
309 |
SYNAPSE ORGANIZATION |
26 |
145 |
1.29e-06 |
1.942e-05 |
310 |
REGULATION OF MONOCYTE CHEMOTAXIS |
9 |
20 |
1.409e-06 |
2.114e-05 |
311 |
PROTEIN PHOSPHORYLATION |
97 |
944 |
1.422e-06 |
2.127e-05 |
312 |
REGULATION OF HORMONE LEVELS |
58 |
478 |
1.435e-06 |
2.134e-05 |
313 |
MUSCLE CELL DEVELOPMENT |
24 |
128 |
1.433e-06 |
2.134e-05 |
314 |
PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS |
176 |
1977 |
1.457e-06 |
2.159e-05 |
315 |
POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION |
21 |
103 |
1.576e-06 |
2.321e-05 |
316 |
REGULATION OF MUSCLE ORGAN DEVELOPMENT |
21 |
103 |
1.576e-06 |
2.321e-05 |
317 |
REGULATION OF NEUROTRANSMITTER TRANSPORT |
16 |
64 |
1.636e-06 |
2.401e-05 |
318 |
CARDIAC MUSCLE CELL ACTION POTENTIAL |
12 |
37 |
1.653e-06 |
2.412e-05 |
319 |
AXON EXTENSION |
12 |
37 |
1.653e-06 |
2.412e-05 |
320 |
BONE DEVELOPMENT |
27 |
156 |
1.659e-06 |
2.413e-05 |
321 |
REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING |
35 |
233 |
1.673e-06 |
2.426e-05 |
322 |
REGULATION OF OSTEOBLAST DIFFERENTIATION |
22 |
112 |
1.734e-06 |
2.497e-05 |
323 |
CELLULAR RESPONSE TO PEPTIDE |
39 |
274 |
1.732e-06 |
2.497e-05 |
324 |
POSITIVE REGULATION OF CYTOKINE PRODUCTION |
48 |
370 |
1.798e-06 |
2.582e-05 |
325 |
ENDOTHELIAL CELL DIFFERENTIATION |
17 |
72 |
1.844e-06 |
2.633e-05 |
326 |
NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS |
23 |
121 |
1.845e-06 |
2.633e-05 |
327 |
POSITIVE REGULATION OF IMMUNE RESPONSE |
65 |
563 |
1.925e-06 |
2.739e-05 |
328 |
RESPONSE TO ORGANOPHOSPHORUS |
25 |
139 |
1.936e-06 |
2.746e-05 |
329 |
BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS |
13 |
44 |
2.017e-06 |
2.852e-05 |
330 |
REGULATION OF STEM CELL DIFFERENTIATION |
22 |
113 |
2.026e-06 |
2.856e-05 |
331 |
REGULATION OF NEUROTRANSMITTER SECRETION |
14 |
51 |
2.179e-06 |
3.063e-05 |
332 |
CEREBRAL CORTEX DEVELOPMENT |
21 |
105 |
2.186e-06 |
3.064e-05 |
333 |
REGULATION OF LEUKOCYTE MIGRATION |
26 |
149 |
2.194e-06 |
3.066e-05 |
334 |
RESPONSE TO ALCOHOL |
47 |
362 |
2.245e-06 |
3.128e-05 |
335 |
REGULATION OF MAP KINASE ACTIVITY |
43 |
319 |
2.259e-06 |
3.137e-05 |
336 |
COLLAGEN FIBRIL ORGANIZATION |
12 |
38 |
2.278e-06 |
3.154e-05 |
337 |
SIALYLATION |
9 |
21 |
2.326e-06 |
3.212e-05 |
338 |
MULTICELLULAR ORGANISMAL SIGNALING |
23 |
123 |
2.476e-06 |
3.408e-05 |
339 |
REGULATION OF ENDOTHELIAL CELL PROLIFERATION |
20 |
98 |
2.732e-06 |
3.75e-05 |
340 |
CARDIAC MUSCLE CELL DIFFERENTIATION |
17 |
74 |
2.767e-06 |
3.775e-05 |
341 |
ACTIN MEDIATED CELL CONTRACTION |
17 |
74 |
2.767e-06 |
3.775e-05 |
342 |
REGULATION OF SEQUESTERING OF CALCIUM ION |
21 |
107 |
3.005e-06 |
4.076e-05 |
343 |
REGULATION OF T CELL DIFFERENTIATION |
21 |
107 |
3.005e-06 |
4.076e-05 |
344 |
NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION |
32 |
209 |
3.041e-06 |
4.113e-05 |
345 |
MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL |
12 |
39 |
3.101e-06 |
4.183e-05 |
346 |
REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL |
17 |
75 |
3.369e-06 |
4.517e-05 |
347 |
NEURAL CREST CELL DIFFERENTIATION |
17 |
75 |
3.369e-06 |
4.517e-05 |
348 |
CHONDROCYTE DIFFERENTIATION |
15 |
60 |
3.444e-06 |
4.605e-05 |
349 |
REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE |
14 |
53 |
3.597e-06 |
4.796e-05 |
350 |
REGULATION OF INTRACELLULAR TRANSPORT |
69 |
621 |
3.631e-06 |
4.827e-05 |
351 |
REGULATION OF CYTOPLASMIC TRANSPORT |
57 |
481 |
3.698e-06 |
4.902e-05 |
352 |
CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION |
9 |
22 |
3.716e-06 |
4.912e-05 |
353 |
REGULATION OF NUCLEOTIDE METABOLIC PROCESS |
32 |
211 |
3.74e-06 |
4.93e-05 |
354 |
NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
37 |
262 |
3.816e-06 |
5.016e-05 |
355 |
POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION |
16 |
68 |
3.87e-06 |
5.073e-05 |
356 |
EYE DEVELOPMENT |
43 |
326 |
3.988e-06 |
5.212e-05 |
357 |
NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH |
18 |
84 |
4.118e-06 |
5.368e-05 |
358 |
REGULATION OF BMP SIGNALING PATHWAY |
17 |
77 |
4.937e-06 |
6.417e-05 |
359 |
SECRETION BY CELL |
57 |
486 |
5.08e-06 |
6.584e-05 |
360 |
TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY |
58 |
498 |
5.222e-06 |
6.75e-05 |
361 |
POSITIVE REGULATION OF DEVELOPMENTAL GROWTH |
26 |
156 |
5.271e-06 |
6.794e-05 |
362 |
RESPONSE TO ACID CHEMICAL |
42 |
319 |
5.387e-06 |
6.924e-05 |
363 |
CELL SUBSTRATE JUNCTION ASSEMBLY |
12 |
41 |
5.566e-06 |
7.134e-05 |
364 |
ATRIAL SEPTUM DEVELOPMENT |
8 |
18 |
6.225e-06 |
7.935e-05 |
365 |
GANGLIOSIDE BIOSYNTHETIC PROCESS |
8 |
18 |
6.225e-06 |
7.935e-05 |
366 |
RESPONSE TO MONOAMINE |
11 |
35 |
6.357e-06 |
8.082e-05 |
367 |
CARDIAC MUSCLE CELL CONTRACTION |
10 |
29 |
6.578e-06 |
8.34e-05 |
368 |
ION TRANSPORT |
119 |
1262 |
6.614e-06 |
8.362e-05 |
369 |
RESPONSE TO CAMP |
20 |
104 |
7.093e-06 |
8.944e-05 |
370 |
MULTICELLULAR ORGANISMAL MACROMOLECULE METABOLIC PROCESS |
17 |
79 |
7.133e-06 |
8.97e-05 |
371 |
GLOMERULUS DEVELOPMENT |
13 |
49 |
7.581e-06 |
9.508e-05 |
372 |
REGULATION OF STEM CELL PROLIFERATION |
18 |
88 |
8.23e-06 |
0.0001029 |
373 |
REGULATION OF LYMPHOCYTE DIFFERENTIATION |
23 |
132 |
8.521e-06 |
0.0001063 |
374 |
GLAND MORPHOGENESIS |
19 |
97 |
9.043e-06 |
0.0001125 |
375 |
CYCLIC NUCLEOTIDE METABOLIC PROCESS |
14 |
57 |
9.072e-06 |
0.0001126 |
376 |
ATRIAL SEPTUM MORPHOGENESIS |
7 |
14 |
9.264e-06 |
0.0001143 |
377 |
POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE |
7 |
14 |
9.264e-06 |
0.0001143 |
378 |
RESPONSE TO PEPTIDE |
49 |
404 |
9.36e-06 |
0.0001152 |
379 |
REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC |
13 |
50 |
9.655e-06 |
0.0001176 |
380 |
REGULATION OF HORMONE SECRETION |
36 |
262 |
9.588e-06 |
0.0001176 |
381 |
CELLULAR RESPONSE TO CAMP |
13 |
50 |
9.655e-06 |
0.0001176 |
382 |
POSITIVE REGULATION OF STEM CELL DIFFERENTIATION |
13 |
50 |
9.655e-06 |
0.0001176 |
383 |
REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS |
15 |
65 |
9.959e-06 |
0.000121 |
384 |
REGULATION OF MUSCLE CELL DIFFERENTIATION |
25 |
152 |
1.009e-05 |
0.0001222 |
385 |
RESPONSE TO REACTIVE OXYGEN SPECIES |
29 |
191 |
1.026e-05 |
0.000124 |
386 |
REGULATION OF ORGAN GROWTH |
16 |
73 |
1.029e-05 |
0.000124 |
387 |
METAL ION TRANSPORT |
64 |
582 |
1.134e-05 |
0.000136 |
388 |
NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
77 |
740 |
1.132e-05 |
0.000136 |
389 |
CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION |
11 |
37 |
1.159e-05 |
0.0001386 |
390 |
VASCULAR PROCESS IN CIRCULATORY SYSTEM |
26 |
163 |
1.19e-05 |
0.000142 |
391 |
NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS |
137 |
1517 |
1.196e-05 |
0.0001422 |
392 |
NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION |
24 |
144 |
1.198e-05 |
0.0001422 |
393 |
KIDNEY MORPHOGENESIS |
17 |
82 |
1.208e-05 |
0.0001426 |
394 |
CARDIAC CONDUCTION |
17 |
82 |
1.208e-05 |
0.0001426 |
395 |
ARTERY MORPHOGENESIS |
13 |
51 |
1.221e-05 |
0.0001435 |
396 |
POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION |
13 |
51 |
1.221e-05 |
0.0001435 |
397 |
NEGATIVE REGULATION OF PROTEIN SECRETION |
20 |
108 |
1.28e-05 |
0.00015 |
398 |
REGULATION OF WOUND HEALING |
22 |
126 |
1.284e-05 |
0.0001501 |
399 |
CARDIAC ATRIUM DEVELOPMENT |
10 |
31 |
1.296e-05 |
0.0001504 |
400 |
REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION |
10 |
31 |
1.296e-05 |
0.0001504 |
401 |
REGULATION OF PLATELET ACTIVATION |
10 |
31 |
1.296e-05 |
0.0001504 |
402 |
REGULATION OF CYCLIC NUCLEOTIDE METABOLIC PROCESS |
25 |
155 |
1.43e-05 |
0.0001651 |
403 |
PROTEOGLYCAN METABOLIC PROCESS |
17 |
83 |
1.43e-05 |
0.0001651 |
404 |
SENSORY PERCEPTION OF PAIN |
16 |
75 |
1.48e-05 |
0.0001705 |
405 |
DIVALENT INORGANIC CATION TRANSPORT |
36 |
268 |
1.59e-05 |
0.0001826 |
406 |
SPROUTING ANGIOGENESIS |
12 |
45 |
1.601e-05 |
0.0001831 |
407 |
NEGATIVE REGULATION OF RESPONSE TO WOUNDING |
25 |
156 |
1.602e-05 |
0.0001831 |
408 |
CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS |
7 |
15 |
1.642e-05 |
0.0001872 |
409 |
REGULATION OF EXTENT OF CELL GROWTH |
19 |
101 |
1.658e-05 |
0.0001886 |
410 |
NEURON MIGRATION |
20 |
110 |
1.697e-05 |
0.0001926 |
411 |
REGULATION OF SMOOTH MUSCLE CONTRACTION |
14 |
60 |
1.711e-05 |
0.0001937 |
412 |
REGULATION OF CALCIUM MEDIATED SIGNALING |
16 |
76 |
1.766e-05 |
0.0001992 |
413 |
REGULATION OF ALPHA BETA T CELL ACTIVATION |
15 |
68 |
1.781e-05 |
0.0001992 |
414 |
REGULATION OF CELL JUNCTION ASSEMBLY |
15 |
68 |
1.781e-05 |
0.0001992 |
415 |
REGULATION OF ACTIN FILAMENT BASED MOVEMENT |
10 |
32 |
1.779e-05 |
0.0001992 |
416 |
ADIPOSE TISSUE DEVELOPMENT |
10 |
32 |
1.779e-05 |
0.0001992 |
417 |
REGULATION OF TYPE 2 IMMUNE RESPONSE |
9 |
26 |
1.853e-05 |
0.0002062 |
418 |
GANGLIOSIDE METABOLIC PROCESS |
9 |
26 |
1.853e-05 |
0.0002062 |
419 |
REGULATION OF CAMP METABOLIC PROCESS |
22 |
129 |
1.884e-05 |
0.0002092 |
420 |
RENAL SYSTEM PROCESS |
19 |
102 |
1.918e-05 |
0.0002125 |
421 |
CARDIAC SEPTUM DEVELOPMENT |
17 |
85 |
1.988e-05 |
0.0002192 |
422 |
SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION |
48 |
404 |
1.983e-05 |
0.0002192 |
423 |
REGULATION OF TRANSPORTER ACTIVITY |
29 |
198 |
2.064e-05 |
0.000227 |
424 |
ACTOMYOSIN STRUCTURE ORGANIZATION |
16 |
77 |
2.1e-05 |
0.0002304 |
425 |
GLYCOSPHINGOLIPID METABOLIC PROCESS |
15 |
69 |
2.144e-05 |
0.0002331 |
426 |
ACTION POTENTIAL |
18 |
94 |
2.136e-05 |
0.0002331 |
427 |
NEGATIVE REGULATION OF OSSIFICATION |
15 |
69 |
2.144e-05 |
0.0002331 |
428 |
POSITIVE REGULATION OF AXONOGENESIS |
15 |
69 |
2.144e-05 |
0.0002331 |
429 |
REGULATION OF CALCIUM ION IMPORT |
19 |
103 |
2.215e-05 |
0.0002402 |
430 |
GLAND DEVELOPMENT |
47 |
395 |
2.322e-05 |
0.0002512 |
431 |
NEURON RECOGNITION |
10 |
33 |
2.408e-05 |
0.0002594 |
432 |
RESPONSE TO VITAMIN D |
10 |
33 |
2.408e-05 |
0.0002594 |
433 |
POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION |
22 |
131 |
2.415e-05 |
0.0002595 |
434 |
LYMPHOCYTE COSTIMULATION |
16 |
78 |
2.488e-05 |
0.0002667 |
435 |
NEGATIVE REGULATION OF CELL GROWTH |
26 |
170 |
2.54e-05 |
0.0002712 |
436 |
FOREBRAIN CELL MIGRATION |
14 |
62 |
2.547e-05 |
0.0002712 |
437 |
RESPONSE TO DRUG |
50 |
431 |
2.546e-05 |
0.0002712 |
438 |
REGULATION OF CARDIAC MUSCLE CELL CONTRACTION |
9 |
27 |
2.623e-05 |
0.0002787 |
439 |
CELL DEATH |
96 |
1001 |
2.776e-05 |
0.0002942 |
440 |
REGULATION OF ENDOTHELIAL CELL MIGRATION |
20 |
114 |
2.917e-05 |
0.0003085 |
441 |
REGULATION OF KIDNEY DEVELOPMENT |
13 |
55 |
2.937e-05 |
0.0003087 |
442 |
REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL |
13 |
55 |
2.937e-05 |
0.0003087 |
443 |
BONE MORPHOGENESIS |
16 |
79 |
2.939e-05 |
0.0003087 |
444 |
REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS |
24 |
152 |
3.018e-05 |
0.0003163 |
445 |
POSITIVE REGULATION OF PURINE NUCLEOTIDE METABOLIC PROCESS |
22 |
133 |
3.075e-05 |
0.0003209 |
446 |
POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS |
22 |
133 |
3.075e-05 |
0.0003209 |
447 |
NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS |
14 |
63 |
3.086e-05 |
0.0003212 |
448 |
HEART VALVE DEVELOPMENT |
10 |
34 |
3.219e-05 |
0.0003344 |
449 |
MYOFIBRIL ASSEMBLY |
12 |
48 |
3.25e-05 |
0.000336 |
450 |
REGULATION OF INTERLEUKIN 2 PRODUCTION |
12 |
48 |
3.25e-05 |
0.000336 |
451 |
REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY |
24 |
153 |
3.369e-05 |
0.0003476 |
452 |
POSITIVE REGULATION OF KIDNEY DEVELOPMENT |
11 |
41 |
3.387e-05 |
0.0003479 |
453 |
AORTA DEVELOPMENT |
11 |
41 |
3.387e-05 |
0.0003479 |
454 |
REGULATION OF PEPTIDE TRANSPORT |
34 |
256 |
3.427e-05 |
0.0003512 |
455 |
POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION |
16 |
80 |
3.46e-05 |
0.0003538 |
456 |
POSITIVE REGULATION OF TRANSFERASE ACTIVITY |
65 |
616 |
3.544e-05 |
0.0003616 |
457 |
POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT |
13 |
56 |
3.605e-05 |
0.0003671 |
458 |
REGULATION OF SPROUTING ANGIOGENESIS |
9 |
28 |
3.65e-05 |
0.0003708 |
459 |
REGULATION OF CELL GROWTH |
46 |
391 |
3.747e-05 |
0.0003798 |
460 |
NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY |
18 |
98 |
3.835e-05 |
0.0003879 |
461 |
PLATELET DEGRANULATION |
19 |
107 |
3.851e-05 |
0.0003887 |
462 |
NEGATIVE REGULATION OF MAPK CASCADE |
23 |
145 |
4.071e-05 |
0.0004092 |
463 |
ADENYLATE CYCLASE MODULATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY |
23 |
145 |
4.071e-05 |
0.0004092 |
464 |
POSITIVE REGULATION OF HOMEOSTATIC PROCESS |
30 |
216 |
4.199e-05 |
0.000421 |
465 |
NEGATIVE REGULATION OF MAP KINASE ACTIVITY |
15 |
73 |
4.334e-05 |
0.000429 |
466 |
POSITIVE REGULATION OF STAT CASCADE |
15 |
73 |
4.334e-05 |
0.000429 |
467 |
CELLULAR RESPONSE TO KETONE |
15 |
73 |
4.334e-05 |
0.000429 |
468 |
REGULATION OF HEART GROWTH |
11 |
42 |
4.328e-05 |
0.000429 |
469 |
POSITIVE REGULATION OF JAK STAT CASCADE |
15 |
73 |
4.334e-05 |
0.000429 |
470 |
MESONEPHROS DEVELOPMENT |
17 |
90 |
4.309e-05 |
0.000429 |
471 |
STRIATED MUSCLE CONTRACTION |
18 |
99 |
4.414e-05 |
0.0004361 |
472 |
REGULATION OF PLATELET AGGREGATION |
7 |
17 |
4.434e-05 |
0.0004371 |
473 |
CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION |
25 |
166 |
4.688e-05 |
0.0004612 |
474 |
INTEGRIN MEDIATED SIGNALING PATHWAY |
16 |
82 |
4.753e-05 |
0.0004656 |
475 |
PATTERN SPECIFICATION PROCESS |
48 |
418 |
4.749e-05 |
0.0004656 |
476 |
SKELETAL MUSCLE ORGAN DEVELOPMENT |
22 |
137 |
4.903e-05 |
0.0004793 |
477 |
INFLAMMATORY RESPONSE |
51 |
454 |
4.978e-05 |
0.0004856 |
478 |
POSITIVE REGULATION OF CARTILAGE DEVELOPMENT |
9 |
29 |
4.996e-05 |
0.0004863 |
479 |
REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION |
19 |
109 |
5.018e-05 |
0.0004874 |
480 |
REGULATION OF OSTEOBLAST PROLIFERATION |
8 |
23 |
5.244e-05 |
0.0005073 |
481 |
RESPONSE TO AUDITORY STIMULUS |
8 |
23 |
5.244e-05 |
0.0005073 |
482 |
PROTEOGLYCAN BIOSYNTHETIC PROCESS |
13 |
58 |
5.348e-05 |
0.0005163 |
483 |
NEGATIVE REGULATION OF CELL CELL ADHESION |
22 |
138 |
5.49e-05 |
0.0005278 |
484 |
CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS |
11 |
43 |
5.486e-05 |
0.0005278 |
485 |
REGULATION OF POTASSIUM ION TRANSPORT |
16 |
83 |
5.547e-05 |
0.000532 |
486 |
T CELL SELECTION |
10 |
36 |
5.557e-05 |
0.000532 |
487 |
REGULATION OF PEPTIDE SECRETION |
29 |
209 |
5.696e-05 |
0.0005442 |
488 |
FORMATION OF PRIMARY GERM LAYER |
19 |
110 |
5.711e-05 |
0.0005446 |
489 |
SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION |
42 |
352 |
5.811e-05 |
0.0005529 |
490 |
CELLULAR RESPONSE TO FATTY ACID |
12 |
51 |
6.208e-05 |
0.0005895 |
491 |
REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION |
14 |
67 |
6.37e-05 |
0.0006036 |
492 |
AGING |
34 |
264 |
6.425e-05 |
0.0006076 |
493 |
REGULATION OF TRANSFERASE ACTIVITY |
90 |
946 |
6.621e-05 |
0.0006249 |
494 |
TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
27 |
190 |
6.694e-05 |
0.0006305 |
495 |
REGULATION OF HEART RATE BY CARDIAC CONDUCTION |
9 |
30 |
6.738e-05 |
0.0006334 |
496 |
POSITIVE REGULATION OF PROTEIN SECRETION |
29 |
211 |
6.78e-05 |
0.0006361 |
497 |
POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC |
7 |
18 |
6.86e-05 |
0.000641 |
498 |
CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS |
7 |
18 |
6.86e-05 |
0.000641 |
499 |
EXTRACELLULAR MATRIX DISASSEMBLY |
15 |
76 |
7.08e-05 |
0.0006602 |
500 |
NEGATIVE REGULATION OF GENE EXPRESSION |
131 |
1493 |
7.153e-05 |
0.0006656 |
501 |
POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION |
10 |
37 |
7.185e-05 |
0.0006673 |
502 |
RESPONSE TO STEROID HORMONE |
54 |
497 |
7.43e-05 |
0.0006874 |
503 |
CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS |
8 |
24 |
7.431e-05 |
0.0006874 |
504 |
LOCOMOTORY BEHAVIOR |
26 |
181 |
7.549e-05 |
0.0006969 |
505 |
NEGATIVE REGULATION OF NEURON DEATH |
25 |
171 |
7.703e-05 |
0.0007097 |
506 |
RESPONSE TO OXYGEN LEVELS |
38 |
311 |
7.767e-05 |
0.0007142 |
507 |
CATION TRANSPORT |
78 |
796 |
7.82e-05 |
0.0007177 |
508 |
RESPONSE TO BIOTIC STIMULUS |
85 |
886 |
7.908e-05 |
0.0007243 |
509 |
ION TRANSMEMBRANE TRANSPORT |
80 |
822 |
7.972e-05 |
0.0007288 |
510 |
PHOSPHORYLATION |
111 |
1228 |
8.119e-05 |
0.0007407 |
511 |
REGULATED EXOCYTOSIS |
30 |
224 |
8.298e-05 |
0.0007556 |
512 |
EMBRYONIC ORGAN MORPHOGENESIS |
35 |
279 |
8.646e-05 |
0.0007812 |
513 |
NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY |
24 |
162 |
8.596e-05 |
0.0007812 |
514 |
ENDOCHONDRAL BONE MORPHOGENESIS |
11 |
45 |
8.614e-05 |
0.0007812 |
515 |
ACTIVATION OF PROTEIN KINASE ACTIVITY |
35 |
279 |
8.646e-05 |
0.0007812 |
516 |
POSITIVE REGULATION OF T CELL PROLIFERATION |
17 |
95 |
8.766e-05 |
0.0007904 |
517 |
POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION |
9 |
31 |
8.965e-05 |
0.0008053 |
518 |
REGULATION OF SYNAPTIC VESICLE TRANSPORT |
9 |
31 |
8.965e-05 |
0.0008053 |
519 |
RESPONSE TO EXTRACELLULAR STIMULUS |
49 |
441 |
9.115e-05 |
0.0008172 |
520 |
REGULATION OF CANONICAL WNT SIGNALING PATHWAY |
31 |
236 |
9.186e-05 |
0.0008219 |
521 |
POSITIVE REGULATION OF ORGAN GROWTH |
10 |
38 |
9.203e-05 |
0.0008219 |
522 |
NEURON PROJECTION EXTENSION |
12 |
53 |
9.276e-05 |
0.0008268 |
523 |
TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
72 |
724 |
9.297e-05 |
0.0008271 |
524 |
POSITIVE REGULATION OF HEMOPOIESIS |
24 |
163 |
9.487e-05 |
0.0008424 |
525 |
MOVEMENT IN ENVIRONMENT OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION |
16 |
87 |
0.0001001 |
0.0008753 |
526 |
ENTRY INTO CELL OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION |
16 |
87 |
0.0001001 |
0.0008753 |
527 |
VIRAL ENTRY INTO HOST CELL |
16 |
87 |
0.0001001 |
0.0008753 |
528 |
ENTRY INTO OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION |
16 |
87 |
0.0001001 |
0.0008753 |
529 |
MOVEMENT IN HOST ENVIRONMENT |
16 |
87 |
0.0001001 |
0.0008753 |
530 |
ENTRY INTO HOST |
16 |
87 |
0.0001001 |
0.0008753 |
531 |
ENTRY INTO HOST CELL |
16 |
87 |
0.0001001 |
0.0008753 |
532 |
INOSITOL LIPID MEDIATED SIGNALING |
20 |
124 |
9.975e-05 |
0.0008753 |
533 |
POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION |
7 |
19 |
0.0001027 |
0.0008965 |
534 |
CHONDROITIN SULFATE BIOSYNTHETIC PROCESS |
8 |
25 |
0.0001032 |
0.0008994 |
535 |
INTERACTION WITH HOST |
21 |
134 |
0.0001034 |
0.0008994 |
536 |
CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT |
14 |
70 |
0.0001053 |
0.0009124 |
537 |
REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY |
14 |
70 |
0.0001053 |
0.0009124 |
538 |
RESPONSE TO INTERLEUKIN 1 |
19 |
115 |
0.0001061 |
0.000918 |
539 |
CYCLIC NUCLEOTIDE MEDIATED SIGNALING |
11 |
46 |
0.0001068 |
0.0009202 |
540 |
REGULATION OF ALPHA BETA T CELL DIFFERENTIATION |
11 |
46 |
0.0001068 |
0.0009202 |
541 |
POSITIVE REGULATION OF CALCIUM ION TRANSPORT |
18 |
106 |
0.0001113 |
0.0009555 |
542 |
CARDIAC VENTRICLE DEVELOPMENT |
18 |
106 |
0.0001113 |
0.0009555 |
543 |
NEGATIVE CHEMOTAXIS |
10 |
39 |
0.0001168 |
0.001001 |
544 |
ENDOCARDIAL CUSHION DEVELOPMENT |
9 |
32 |
0.0001178 |
0.001007 |
545 |
POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION |
6 |
14 |
0.0001228 |
0.001046 |
546 |
POSITIVE REGULATION OF SPROUTING ANGIOGENESIS |
6 |
14 |
0.0001228 |
0.001046 |
547 |
REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
27 |
197 |
0.0001248 |
0.001062 |
548 |
GLIAL CELL DIFFERENTIATION |
21 |
136 |
0.0001284 |
0.00109 |
549 |
REGULATION OF NEURON DEATH |
32 |
252 |
0.0001358 |
0.001151 |
550 |
DEFENSE RESPONSE |
110 |
1231 |
0.0001377 |
0.001165 |
551 |
POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION |
8 |
26 |
0.0001409 |
0.00119 |
552 |
CELLULAR RESPONSE TO EXTERNAL STIMULUS |
33 |
264 |
0.0001455 |
0.001226 |
553 |
NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION |
10 |
40 |
0.000147 |
0.001237 |
554 |
POSITIVE REGULATION OF CELL SUBSTRATE ADHESION |
17 |
99 |
0.0001485 |
0.001247 |
555 |
MELANOCYTE DIFFERENTIATION |
7 |
20 |
0.0001494 |
0.001252 |
556 |
CYTOSKELETON ORGANIZATION |
80 |
838 |
0.0001498 |
0.001253 |
557 |
METANEPHROS DEVELOPMENT |
15 |
81 |
0.0001508 |
0.00126 |
558 |
REGULATION OF WNT SIGNALING PATHWAY |
37 |
310 |
0.0001554 |
0.001296 |
559 |
NEGATIVE REGULATION OF HEMOPOIESIS |
20 |
128 |
0.0001561 |
0.001298 |
560 |
REGULATION OF PHOSPHOLIPASE ACTIVITY |
13 |
64 |
0.0001563 |
0.001298 |
561 |
REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY |
30 |
232 |
0.000157 |
0.001302 |
562 |
REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT |
11 |
48 |
0.000161 |
0.00133 |
563 |
POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS |
11 |
48 |
0.000161 |
0.00133 |
564 |
POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING |
25 |
179 |
0.0001621 |
0.001337 |
565 |
EPITHELIAL TO MESENCHYMAL TRANSITION |
12 |
56 |
0.0001628 |
0.001341 |
566 |
NEGATIVE REGULATION OF CYTOKINE PRODUCTION |
28 |
211 |
0.0001652 |
0.001358 |
567 |
REGIONALIZATION |
37 |
311 |
0.0001659 |
0.001361 |
568 |
REGULATION OF CELL SHAPE |
21 |
139 |
0.0001758 |
0.00144 |
569 |
POSITIVE REGULATION OF SECRETION |
42 |
370 |
0.0001775 |
0.001452 |
570 |
POSITIVE REGULATION OF SYNAPTIC TRANSMISSION |
18 |
110 |
0.0001809 |
0.001477 |
571 |
CALCIUM ION TRANSPORT |
29 |
223 |
0.0001817 |
0.001481 |
572 |
POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS |
45 |
406 |
0.0001835 |
0.001492 |
573 |
POSITIVE REGULATION OF HEART GROWTH |
8 |
27 |
0.0001892 |
0.001531 |
574 |
POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION |
8 |
27 |
0.0001892 |
0.001531 |
575 |
HETEROTYPIC CELL CELL ADHESION |
8 |
27 |
0.0001892 |
0.001531 |
576 |
AZOLE TRANSPORT |
6 |
15 |
0.0001936 |
0.001564 |
577 |
REGULATION OF MESENCHYMAL CELL PROLIFERATION |
9 |
34 |
0.0001963 |
0.001575 |
578 |
RESPONSE TO PROSTAGLANDIN |
9 |
34 |
0.0001963 |
0.001575 |
579 |
CAMP METABOLIC PROCESS |
9 |
34 |
0.0001963 |
0.001575 |
580 |
CARDIAC SEPTUM MORPHOGENESIS |
11 |
49 |
0.0001958 |
0.001575 |
581 |
REGULATION OF CELLULAR COMPONENT SIZE |
39 |
337 |
0.0002002 |
0.0016 |
582 |
RESPONSE TO FATTY ACID |
15 |
83 |
2e-04 |
0.0016 |
583 |
REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION |
27 |
203 |
0.0002064 |
0.001647 |
584 |
CHONDROCYTE DEVELOPMENT |
7 |
21 |
0.0002119 |
0.001675 |
585 |
RESPONSE TO KETONE |
25 |
182 |
0.000211 |
0.001675 |
586 |
CELL AGGREGATION |
7 |
21 |
0.0002119 |
0.001675 |
587 |
REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS |
7 |
21 |
0.0002119 |
0.001675 |
588 |
RESPONSE TO VIRUS |
31 |
247 |
0.000212 |
0.001675 |
589 |
CARTILAGE CONDENSATION |
7 |
21 |
0.0002119 |
0.001675 |
590 |
REGULATION OF VASOCONSTRICTION |
13 |
66 |
0.0002162 |
0.0017 |
591 |
REGULATION OF CARDIAC MUSCLE CONTRACTION |
13 |
66 |
0.0002162 |
0.0017 |
592 |
NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION |
17 |
102 |
0.0002158 |
0.0017 |
593 |
G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER |
24 |
172 |
0.0002202 |
0.001728 |
594 |
POSITIVE REGULATION OF BLOOD CIRCULATION |
16 |
93 |
0.000225 |
0.001763 |
595 |
NEGATIVE REGULATION OF BMP SIGNALING PATHWAY |
10 |
42 |
0.0002272 |
0.001774 |
596 |
MULTI ORGANISM BEHAVIOR |
14 |
75 |
0.0002272 |
0.001774 |
597 |
REGULATION OF MYELOID CELL DIFFERENTIATION |
25 |
183 |
0.00023 |
0.00179 |
598 |
REGULATION OF PROTEIN IMPORT |
25 |
183 |
0.00023 |
0.00179 |
599 |
REGULATION OF DEFENSE RESPONSE |
73 |
759 |
0.0002314 |
0.001798 |
600 |
REGULATION OF EPITHELIAL CELL DIFFERENTIATION |
19 |
122 |
0.0002357 |
0.001828 |
601 |
REGULATION OF INFLAMMATORY RESPONSE |
35 |
294 |
0.0002428 |
0.00188 |
602 |
INORGANIC ION TRANSMEMBRANE TRANSPORT |
59 |
583 |
0.0002477 |
0.001915 |
603 |
REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS |
16 |
94 |
0.0002555 |
0.001965 |
604 |
RESPONSE TO BMP |
16 |
94 |
0.0002555 |
0.001965 |
605 |
CELLULAR RESPONSE TO BMP STIMULUS |
16 |
94 |
0.0002555 |
0.001965 |
606 |
REGULATION OF ADAPTIVE IMMUNE RESPONSE |
19 |
123 |
0.0002625 |
0.002013 |
607 |
REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION |
15 |
85 |
0.0002626 |
0.002013 |
608 |
VASCULOGENESIS |
12 |
59 |
0.0002738 |
0.002096 |
609 |
NEGATIVE REGULATION OF MOLECULAR FUNCTION |
97 |
1079 |
0.0002775 |
0.00212 |
610 |
CERAMIDE BIOSYNTHETIC PROCESS |
10 |
43 |
0.0002795 |
0.002132 |
611 |
NEURAL CREST CELL MIGRATION |
11 |
51 |
0.0002849 |
0.002166 |
612 |
NEGATIVE REGULATION OF CHEMOTAXIS |
11 |
51 |
0.0002849 |
0.002166 |
613 |
NEGATIVE REGULATION OF MUSCLE CONTRACTION |
7 |
22 |
0.0002939 |
0.002209 |
614 |
NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION |
6 |
16 |
0.0002933 |
0.002209 |
615 |
POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION |
7 |
22 |
0.0002939 |
0.002209 |
616 |
PROTEIN LOCALIZATION TO CELL SURFACE |
7 |
22 |
0.0002939 |
0.002209 |
617 |
RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE |
6 |
16 |
0.0002933 |
0.002209 |
618 |
RESPONSE TO EPINEPHRINE |
6 |
16 |
0.0002933 |
0.002209 |
619 |
CELLULAR RESPONSE TO INTERLEUKIN 6 |
7 |
22 |
0.0002939 |
0.002209 |
620 |
NERVE DEVELOPMENT |
13 |
68 |
0.0002949 |
0.002213 |
621 |
RESPIRATORY SYSTEM DEVELOPMENT |
26 |
197 |
0.0003033 |
0.002272 |
622 |
GASTRULATION |
22 |
155 |
0.0003104 |
0.002322 |
623 |
POSITIVE REGULATION OF AXON EXTENSION |
9 |
36 |
0.0003143 |
0.002343 |
624 |
RHYTHMIC PROCESS |
35 |
298 |
0.0003142 |
0.002343 |
625 |
NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION |
18 |
115 |
0.0003194 |
0.002378 |
626 |
POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION |
12 |
60 |
0.0003228 |
0.0024 |
627 |
NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS |
20 |
135 |
0.0003236 |
0.002402 |
628 |
REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION |
8 |
29 |
0.0003266 |
0.002416 |
629 |
MUSCLE ADAPTATION |
8 |
29 |
0.0003266 |
0.002416 |
630 |
REGULATION OF LEUKOCYTE CHEMOTAXIS |
16 |
96 |
0.0003273 |
0.002417 |
631 |
REGULATION OF T HELPER 2 CELL DIFFERENTIATION |
5 |
11 |
0.0003375 |
0.002489 |
632 |
POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL |
11 |
52 |
0.0003409 |
0.002502 |
633 |
POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS |
22 |
156 |
0.0003402 |
0.002502 |
634 |
POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION |
11 |
52 |
0.0003409 |
0.002502 |
635 |
PERIPHERAL NERVOUS SYSTEM DEVELOPMENT |
13 |
69 |
0.0003426 |
0.00251 |
636 |
RESPONSE TO BACTERIUM |
54 |
528 |
0.0003454 |
0.002522 |
637 |
ADAPTIVE IMMUNE RESPONSE |
34 |
288 |
0.0003455 |
0.002522 |
638 |
FAT CELL DIFFERENTIATION |
17 |
106 |
0.0003458 |
0.002522 |
639 |
EMBRYONIC ORGAN DEVELOPMENT |
44 |
406 |
0.0003518 |
0.002562 |
640 |
RESPONSE TO INORGANIC SUBSTANCE |
50 |
479 |
0.0003524 |
0.002562 |
641 |
NEGATIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY |
20 |
136 |
0.0003573 |
0.002594 |
642 |
OSTEOBLAST DIFFERENTIATION |
19 |
126 |
0.0003596 |
0.002606 |
643 |
REGULATION OF INTERFERON GAMMA PRODUCTION |
16 |
97 |
0.0003693 |
0.002669 |
644 |
POSITIVE REGULATION OF CATION TRANSMEMBRANE TRANSPORT |
16 |
97 |
0.0003693 |
0.002669 |
645 |
REGULATION OF T CELL PROLIFERATION |
21 |
147 |
0.000385 |
0.002777 |
646 |
OVULATION CYCLE PROCESS |
15 |
88 |
0.0003878 |
0.002793 |
647 |
CORONARY VASCULATURE DEVELOPMENT |
9 |
37 |
0.0003922 |
0.002812 |
648 |
GLIAL CELL MIGRATION |
9 |
37 |
0.0003922 |
0.002812 |
649 |
CAMP MEDIATED SIGNALING |
9 |
37 |
0.0003922 |
0.002812 |
650 |
REGULATION OF RECEPTOR ACTIVITY |
18 |
117 |
0.0003965 |
0.002834 |
651 |
LEUKOCYTE CHEMOTAXIS |
18 |
117 |
0.0003965 |
0.002834 |
652 |
NEGATIVE REGULATION OF ION TRANSPORT |
19 |
127 |
0.0003982 |
0.002842 |
653 |
REGULATION OF METANEPHROS DEVELOPMENT |
7 |
23 |
0.0003995 |
0.002842 |
654 |
INNERVATION |
7 |
23 |
0.0003995 |
0.002842 |
655 |
REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS |
11 |
53 |
0.0004059 |
0.002884 |
656 |
PROTEIN DEPHOSPHORYLATION |
25 |
190 |
0.000411 |
0.002915 |
657 |
SMOOTH MUSCLE CONTRACTION |
10 |
45 |
0.0004143 |
0.002921 |
658 |
REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS |
10 |
45 |
0.0004143 |
0.002921 |
659 |
REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
49 |
470 |
0.0004132 |
0.002921 |
660 |
REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS |
10 |
45 |
0.0004143 |
0.002921 |
661 |
MEMORY |
16 |
98 |
0.0004159 |
0.002928 |
662 |
MEMBRANE BIOGENESIS |
8 |
30 |
0.0004208 |
0.002944 |
663 |
CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS |
8 |
30 |
0.0004208 |
0.002944 |
664 |
POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION |
8 |
30 |
0.0004208 |
0.002944 |
665 |
REGULATION OF MEMBRANE REPOLARIZATION |
8 |
30 |
0.0004208 |
0.002944 |
666 |
NEGATIVE REGULATION OF PLATELET ACTIVATION |
6 |
17 |
0.0004291 |
0.002984 |
667 |
REGULATION OF RECEPTOR BINDING |
6 |
17 |
0.0004291 |
0.002984 |
668 |
NEGATIVE REGULATION OF ANOIKIS |
6 |
17 |
0.0004291 |
0.002984 |
669 |
MATURE B CELL DIFFERENTIATION |
6 |
17 |
0.0004291 |
0.002984 |
670 |
POSITIVE REGULATION OF CAMP METABOLIC PROCESS |
15 |
89 |
0.0004396 |
0.003048 |
671 |
POST EMBRYONIC DEVELOPMENT |
15 |
89 |
0.0004396 |
0.003048 |
672 |
NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION |
12 |
62 |
0.0004433 |
0.003065 |
673 |
CARDIAC VENTRICLE MORPHOGENESIS |
12 |
62 |
0.0004433 |
0.003065 |
674 |
REGULATION OF CYTOKINE SECRETION |
21 |
149 |
0.000463 |
0.003197 |
675 |
SYNAPTIC SIGNALING |
45 |
424 |
0.0004776 |
0.003287 |
676 |
REGULATION OF IMMUNE EFFECTOR PROCESS |
45 |
424 |
0.0004776 |
0.003287 |
677 |
REGULATION OF NEURON APOPTOTIC PROCESS |
25 |
192 |
0.0004817 |
0.00331 |
678 |
POSITIVE REGULATION OF CYCLIC NUCLEOTIDE METABOLIC PROCESS |
17 |
109 |
0.0004834 |
0.003317 |
679 |
CELLULAR RESPONSE TO GLUCAGON STIMULUS |
9 |
38 |
0.0004853 |
0.003321 |
680 |
REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION |
9 |
38 |
0.0004853 |
0.003321 |
681 |
REGULATION OF MUSCLE ADAPTATION |
12 |
63 |
0.0005166 |
0.00353 |
682 |
BLOOD VESSEL ENDOTHELIAL CELL MIGRATION |
7 |
24 |
0.0005334 |
0.003639 |
683 |
REGULATION OF INTERLEUKIN 4 PRODUCTION |
8 |
31 |
0.000536 |
0.003651 |
684 |
NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE |
5 |
12 |
0.0005485 |
0.003694 |
685 |
AXON EXTENSION INVOLVED IN AXON GUIDANCE |
5 |
12 |
0.0005485 |
0.003694 |
686 |
HEMATOPOIETIC STEM CELL DIFFERENTIATION |
5 |
12 |
0.0005485 |
0.003694 |
687 |
REGULATION OF CELL SIZE |
23 |
172 |
0.0005464 |
0.003694 |
688 |
POSITIVE REGULATION OF GROWTH |
29 |
238 |
0.0005458 |
0.003694 |
689 |
CELL ADHESION MEDIATED BY INTEGRIN |
5 |
12 |
0.0005485 |
0.003694 |
690 |
MECHANOSENSORY BEHAVIOR |
5 |
12 |
0.0005485 |
0.003694 |
691 |
POSITIVE REGULATION OF INTERLEUKIN 2 BIOSYNTHETIC PROCESS |
5 |
12 |
0.0005485 |
0.003694 |
692 |
ACTIVATION OF IMMUNE RESPONSE |
45 |
427 |
0.0005552 |
0.003733 |
693 |
DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS |
27 |
216 |
0.000561 |
0.003767 |
694 |
POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
34 |
296 |
0.0005695 |
0.003819 |
695 |
REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE |
16 |
101 |
0.0005872 |
0.003931 |
696 |
NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION |
14 |
82 |
0.0005895 |
0.003941 |
697 |
POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT |
19 |
131 |
0.0005912 |
0.003945 |
698 |
NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
60 |
616 |
0.0005917 |
0.003945 |
699 |
REGULATION OF PHOSPHOLIPASE C ACTIVITY |
9 |
39 |
0.0005959 |
0.003961 |
700 |
EMBRYO IMPLANTATION |
9 |
39 |
0.0005959 |
0.003961 |
701 |
COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION |
17 |
111 |
0.0005993 |
0.003972 |
702 |
POSITIVE REGULATION OF GLIOGENESIS |
10 |
47 |
0.0005993 |
0.003972 |
703 |
CELLULAR RESPONSE TO OXIDATIVE STRESS |
24 |
184 |
0.0006031 |
0.003992 |
704 |
REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION |
13 |
73 |
0.0006045 |
0.003996 |
705 |
ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY |
25 |
195 |
0.0006076 |
0.00401 |
706 |
POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION |
6 |
18 |
0.0006093 |
0.004016 |
707 |
EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING |
55 |
554 |
0.0006289 |
0.004136 |
708 |
DEPHOSPHORYLATION |
33 |
286 |
0.0006293 |
0.004136 |
709 |
EXOCYTOSIS |
35 |
310 |
0.000653 |
0.004286 |
710 |
LOCALIZATION WITHIN MEMBRANE |
18 |
122 |
0.0006628 |
0.004344 |
711 |
REGULATION OF DENDRITIC SPINE DEVELOPMENT |
11 |
56 |
0.0006663 |
0.00436 |
712 |
PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY |
14 |
83 |
0.0006685 |
0.004369 |
713 |
REGULATION OF ORGAN FORMATION |
8 |
32 |
0.0006754 |
0.004389 |
714 |
NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT |
8 |
32 |
0.0006754 |
0.004389 |
715 |
NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND |
8 |
32 |
0.0006754 |
0.004389 |
716 |
NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND |
8 |
32 |
0.0006754 |
0.004389 |
717 |
NEGATIVE REGULATION OF HORMONE SECRETION |
13 |
74 |
0.0006916 |
0.004476 |
718 |
CELL CELL JUNCTION ASSEMBLY |
13 |
74 |
0.0006916 |
0.004476 |
719 |
NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT |
20 |
143 |
0.0006906 |
0.004476 |
720 |
REGULATION OF CHEMOKINE PRODUCTION |
12 |
65 |
0.0006938 |
0.004478 |
721 |
POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION |
12 |
65 |
0.0006938 |
0.004478 |
722 |
RESPONSE TO PROSTAGLANDIN E |
7 |
25 |
0.0007006 |
0.00449 |
723 |
MEMBRANE ASSEMBLY |
7 |
25 |
0.0007006 |
0.00449 |
724 |
POSTSYNAPTIC MEMBRANE ORGANIZATION |
7 |
25 |
0.0007006 |
0.00449 |
725 |
HOMEOSTASIS OF NUMBER OF CELLS |
23 |
175 |
0.0006976 |
0.00449 |
726 |
REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY SARCOPLASMIC RETICULUM |
7 |
25 |
0.0007006 |
0.00449 |
727 |
NEGATIVE REGULATION OF WNT SIGNALING PATHWAY |
25 |
197 |
0.0007067 |
0.004523 |
728 |
POSITIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY |
10 |
48 |
0.0007146 |
0.004567 |
729 |
REPRODUCTIVE SYSTEM DEVELOPMENT |
43 |
408 |
0.0007277 |
0.004645 |
730 |
OVULATION CYCLE |
17 |
113 |
0.0007383 |
0.004706 |
731 |
REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE |
14 |
84 |
0.0007563 |
0.004808 |
732 |
TRANSMEMBRANE TRANSPORT |
96 |
1098 |
0.0007558 |
0.004808 |
733 |
REGULATION OF BIOMINERAL TISSUE DEVELOPMENT |
13 |
75 |
0.000789 |
0.005008 |
734 |
MESODERM MORPHOGENESIS |
12 |
66 |
8e-04 |
0.005071 |
735 |
REGULATION OF INTERLEUKIN 6 PRODUCTION |
16 |
104 |
0.0008155 |
0.005163 |
736 |
FIBRIL ORGANIZATION |
6 |
19 |
0.0008431 |
0.005292 |
737 |
PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION |
5 |
13 |
0.000845 |
0.005292 |
738 |
KIDNEY VASCULATURE DEVELOPMENT |
6 |
19 |
0.0008431 |
0.005292 |
739 |
PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION |
5 |
13 |
0.000845 |
0.005292 |
740 |
CARDIOBLAST DIFFERENTIATION |
5 |
13 |
0.000845 |
0.005292 |
741 |
PERIPHERAL NERVOUS SYSTEM NEURON DEVELOPMENT |
5 |
13 |
0.000845 |
0.005292 |
742 |
RENAL SYSTEM VASCULATURE DEVELOPMENT |
6 |
19 |
0.0008431 |
0.005292 |
743 |
GLIAL CELL FATE COMMITMENT |
5 |
13 |
0.000845 |
0.005292 |
744 |
REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY |
10 |
49 |
0.0008476 |
0.005294 |
745 |
POSITIVE REGULATION OF CHEMOKINE PRODUCTION |
10 |
49 |
0.0008476 |
0.005294 |
746 |
IMMUNE EFFECTOR PROCESS |
49 |
486 |
0.0008698 |
0.005425 |
747 |
REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY |
9 |
41 |
0.0008789 |
0.005475 |
748 |
REGULATION OF T HELPER CELL DIFFERENTIATION |
7 |
26 |
0.0009069 |
0.005606 |
749 |
NEGATIVE REGULATION OF WOUND HEALING |
11 |
58 |
0.0009073 |
0.005606 |
750 |
NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT |
7 |
26 |
0.0009069 |
0.005606 |
751 |
RESPONSE TO INTERLEUKIN 6 |
7 |
26 |
0.0009069 |
0.005606 |
752 |
POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS |
11 |
58 |
0.0009073 |
0.005606 |
753 |
REGULATION OF P38MAPK CASCADE |
7 |
26 |
0.0009069 |
0.005606 |
754 |
POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION |
12 |
67 |
0.0009193 |
0.005673 |
755 |
POSITIVE REGULATION OF DEFENSE RESPONSE |
39 |
364 |
0.0009215 |
0.005679 |
756 |
DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION |
58 |
602 |
0.000942 |
0.005798 |
757 |
REGULATION OF NEUROTRANSMITTER LEVELS |
24 |
190 |
0.000955 |
0.00587 |
758 |
REGULATION OF HEART RATE |
14 |
86 |
0.0009614 |
0.005894 |
759 |
POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS |
14 |
86 |
0.0009614 |
0.005894 |
760 |
GLYCOPROTEIN METABOLIC PROCESS |
38 |
353 |
0.0009754 |
0.005964 |
761 |
NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
18 |
126 |
0.0009751 |
0.005964 |
762 |
REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT |
10 |
50 |
0.001 |
0.006076 |
763 |
REGULATION OF ADHERENS JUNCTION ORGANIZATION |
10 |
50 |
0.001 |
0.006076 |
764 |
STAT CASCADE |
10 |
50 |
0.001 |
0.006076 |
765 |
JAK STAT CASCADE |
10 |
50 |
0.001 |
0.006076 |
766 |
POSITIVE REGULATION OF CYTOKINE SECRETION |
15 |
96 |
0.0009959 |
0.006076 |
767 |
SPINAL CORD DEVELOPMENT |
16 |
106 |
0.001006 |
0.006106 |
768 |
RESPONSE TO NUTRIENT |
24 |
191 |
0.001028 |
0.00623 |
769 |
RESPONSE TO FLUID SHEAR STRESS |
8 |
34 |
0.001041 |
0.006285 |
770 |
POSITIVE REGULATION OF SODIUM ION TRANSPORT |
8 |
34 |
0.001041 |
0.006285 |
771 |
CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS |
8 |
34 |
0.001041 |
0.006285 |
772 |
REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN |
12 |
68 |
0.001053 |
0.006347 |
773 |
NEGATIVE REGULATION OF CYCLIC NUCLEOTIDE METABOLIC PROCESS |
9 |
42 |
0.001057 |
0.00636 |
774 |
TISSUE REMODELING |
14 |
87 |
0.00108 |
0.006494 |
775 |
CALCIUM ION TRANSMEMBRANE TRANSPORT |
21 |
159 |
0.001095 |
0.006573 |
776 |
REGULATION OF AUTOPHAGY |
29 |
249 |
0.001125 |
0.006748 |
777 |
NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY |
6 |
20 |
0.00114 |
0.006794 |
778 |
RESPONSE TO PROTOZOAN |
6 |
20 |
0.00114 |
0.006794 |
779 |
RELAXATION OF MUSCLE |
6 |
20 |
0.00114 |
0.006794 |
780 |
PARTURITION |
6 |
20 |
0.00114 |
0.006794 |
781 |
NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY |
6 |
20 |
0.00114 |
0.006794 |
782 |
SARCOMERE ORGANIZATION |
7 |
27 |
0.001158 |
0.006864 |
783 |
CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES |
7 |
27 |
0.001158 |
0.006864 |
784 |
SUBSTRATE DEPENDENT CELL MIGRATION |
7 |
27 |
0.001158 |
0.006864 |
785 |
AXIS ELONGATION |
7 |
27 |
0.001158 |
0.006864 |
786 |
NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING |
10 |
51 |
0.001175 |
0.006946 |
787 |
NEGATIVE REGULATION OF CALCIUM ION TRANSPORT |
10 |
51 |
0.001175 |
0.006946 |
788 |
REGULATION OF COAGULATION |
14 |
88 |
0.001211 |
0.007134 |
789 |
LEUKOCYTE PROLIFERATION |
14 |
88 |
0.001211 |
0.007134 |
790 |
REGULATION OF CATION CHANNEL ACTIVITY |
14 |
88 |
0.001211 |
0.007134 |
791 |
REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION |
11 |
60 |
0.001216 |
0.007145 |
792 |
MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY |
11 |
60 |
0.001216 |
0.007145 |
793 |
REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION |
16 |
108 |
0.001234 |
0.00724 |
794 |
POSITIVE REGULATION OF METANEPHROS DEVELOPMENT |
5 |
14 |
0.001246 |
0.007267 |
795 |
SENSORY ORGAN MORPHOGENESIS |
28 |
239 |
0.001241 |
0.007267 |
796 |
CELLULAR RESPONSE TO VITAMIN D |
5 |
14 |
0.001246 |
0.007267 |
797 |
ANGIOGENESIS INVOLVED IN WOUND HEALING |
5 |
14 |
0.001246 |
0.007267 |
798 |
POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY |
5 |
14 |
0.001246 |
0.007267 |
799 |
REGULATION OF MUSCLE CELL APOPTOTIC PROCESS |
9 |
43 |
0.001262 |
0.007342 |
800 |
CEREBRAL CORTEX CELL MIGRATION |
9 |
43 |
0.001262 |
0.007342 |
801 |
ANTERIOR POSTERIOR PATTERN SPECIFICATION |
24 |
194 |
0.001278 |
0.007424 |
802 |
REGULATION OF CARBOHYDRATE METABOLIC PROCESS |
22 |
172 |
0.001294 |
0.007505 |
803 |
DENDRITE DEVELOPMENT |
13 |
79 |
0.001301 |
0.007531 |
804 |
REGULATION OF STRIATED MUSCLE CONTRACTION |
13 |
79 |
0.001301 |
0.007531 |
805 |
IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY |
35 |
323 |
0.001352 |
0.007812 |
806 |
RESPONSE TO HEAT |
14 |
89 |
0.001355 |
0.007815 |
807 |
EPITHELIAL CELL PROLIFERATION |
14 |
89 |
0.001355 |
0.007815 |
808 |
MYELOID LEUKOCYTE MIGRATION |
15 |
99 |
0.001373 |
0.00785 |
809 |
REGULATION OF ADENYLATE CYCLASE ACTIVITY |
12 |
70 |
0.001369 |
0.00785 |
810 |
REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
15 |
99 |
0.001373 |
0.00785 |
811 |
MUSCLE ORGAN MORPHOGENESIS |
12 |
70 |
0.001369 |
0.00785 |
812 |
REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS |
15 |
99 |
0.001373 |
0.00785 |
813 |
INTERFERON GAMMA MEDIATED SIGNALING PATHWAY |
12 |
70 |
0.001369 |
0.00785 |
814 |
LIPID PHOSPHORYLATION |
15 |
99 |
0.001373 |
0.00785 |
815 |
POSITIVE REGULATION OF LYASE ACTIVITY |
11 |
61 |
0.0014 |
0.007966 |
816 |
POSITIVE REGULATION OF CYCLASE ACTIVITY |
11 |
61 |
0.0014 |
0.007966 |
817 |
REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT |
11 |
61 |
0.0014 |
0.007966 |
818 |
POSITIVE REGULATION OF STEM CELL PROLIFERATION |
11 |
61 |
0.0014 |
0.007966 |
819 |
REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS |
26 |
218 |
0.001407 |
0.007994 |
820 |
POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE |
7 |
28 |
0.001461 |
0.008256 |
821 |
MUSCLE HYPERTROPHY |
7 |
28 |
0.001461 |
0.008256 |
822 |
POSITIVE REGULATION OF CHEMOTAXIS |
17 |
120 |
0.001462 |
0.008256 |
823 |
REGULATION OF DENDRITE DEVELOPMENT |
17 |
120 |
0.001462 |
0.008256 |
824 |
POSITIVE REGULATION OF PHOSPHATASE ACTIVITY |
7 |
28 |
0.001461 |
0.008256 |
825 |
CALCIUM MEDIATED SIGNALING |
14 |
90 |
0.001513 |
0.008464 |
826 |
DECIDUALIZATION |
6 |
21 |
0.001512 |
0.008464 |
827 |
NEGATIVE REGULATION OF ORGAN GROWTH |
6 |
21 |
0.001512 |
0.008464 |
828 |
PLASMA LIPOPROTEIN PARTICLE CLEARANCE |
6 |
21 |
0.001512 |
0.008464 |
829 |
POSITIVE T CELL SELECTION |
6 |
21 |
0.001512 |
0.008464 |
830 |
POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL |
6 |
21 |
0.001512 |
0.008464 |
831 |
REGULATION OF CELL MATRIX ADHESION |
14 |
90 |
0.001513 |
0.008464 |
832 |
REGULATION OF GLIOGENESIS |
14 |
90 |
0.001513 |
0.008464 |
833 |
POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
15 |
100 |
0.001523 |
0.008498 |
834 |
PEPTIDYL TYROSINE DEPHOSPHORYLATION |
15 |
100 |
0.001523 |
0.008498 |
835 |
RETINA DEVELOPMENT IN CAMERA TYPE EYE |
18 |
131 |
0.001535 |
0.008552 |
836 |
NEUROMUSCULAR JUNCTION DEVELOPMENT |
8 |
36 |
0.001551 |
0.008621 |
837 |
CORTICAL CYTOSKELETON ORGANIZATION |
8 |
36 |
0.001551 |
0.008621 |
838 |
SEX DIFFERENTIATION |
30 |
266 |
0.001556 |
0.008639 |
839 |
POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY |
10 |
53 |
0.001598 |
0.008843 |
840 |
NEGATIVE REGULATION OF AUTOPHAGY |
10 |
53 |
0.001598 |
0.008843 |
841 |
SKELETAL MUSCLE CELL DIFFERENTIATION |
10 |
53 |
0.001598 |
0.008843 |
842 |
NEGATIVE REGULATION OF IMMUNE RESPONSE |
17 |
121 |
0.001603 |
0.008858 |
843 |
GLYCOLIPID BIOSYNTHETIC PROCESS |
11 |
62 |
0.001607 |
0.008869 |
844 |
REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION |
15 |
101 |
0.001686 |
0.009297 |
845 |
CELLULAR RESPONSE TO OXYGEN LEVELS |
19 |
143 |
0.001721 |
0.009477 |
846 |
REGULATION OF CYTOSKELETON ORGANIZATION |
49 |
502 |
0.001728 |
0.009503 |
847 |
POTASSIUM ION TRANSPORT |
20 |
154 |
0.001746 |
0.009581 |
848 |
RESPONSE TO STARVATION |
20 |
154 |
0.001746 |
0.009581 |
849 |
EMBRYONIC SKELETAL SYSTEM DEVELOPMENT |
17 |
122 |
0.001755 |
0.009619 |
850 |
REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY |
5 |
15 |
0.001773 |
0.009624 |
851 |
ENDOTHELIAL CELL DEVELOPMENT |
9 |
45 |
0.00177 |
0.009624 |
852 |
REGULATION OF HEAT GENERATION |
5 |
15 |
0.001773 |
0.009624 |
853 |
REGULATION OF N METHYL D ASPARTATE SELECTIVE GLUTAMATE RECEPTOR ACTIVITY |
5 |
15 |
0.001773 |
0.009624 |
854 |
NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION |
5 |
15 |
0.001773 |
0.009624 |
855 |
RESPONSE TO TUMOR NECROSIS FACTOR |
27 |
233 |
0.001762 |
0.009624 |
856 |
POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS |
5 |
15 |
0.001773 |
0.009624 |
857 |
REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL |
9 |
45 |
0.00177 |
0.009624 |
858 |
REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY |
38 |
365 |
0.00179 |
0.009707 |
859 |
REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION |
7 |
29 |
0.001822 |
0.009832 |
860 |
CARBOHYDRATE DERIVATIVE METABOLIC PROCESS |
90 |
1047 |
0.001819 |
0.009832 |
861 |
PIGMENT CELL DIFFERENTIATION |
7 |
29 |
0.001822 |
0.009832 |
862 |
POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT |
7 |
29 |
0.001822 |
0.009832 |
863 |
NEUROEPITHELIAL CELL DIFFERENTIATION |
11 |
63 |
0.001837 |
0.009907 |
864 |
CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS |
23 |
188 |
0.001848 |
0.009952 |
865 |
ALPHA BETA T CELL ACTIVATION |
10 |
54 |
0.001852 |
0.009952 |
866 |
POSITIVE REGULATION OF CALCIUM ION IMPORT |
10 |
54 |
0.001852 |
0.009952 |
867 |
REGULATION OF JAK STAT CASCADE |
19 |
144 |
0.001868 |
0.009992 |
868 |
REGULATION OF MUSCLE HYPERTROPHY |
8 |
37 |
0.00187 |
0.009992 |
869 |
POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT3 PROTEIN |
8 |
37 |
0.00187 |
0.009992 |
870 |
REGULATION OF RESPONSE TO CYTOKINE STIMULUS |
19 |
144 |
0.001868 |
0.009992 |
871 |
REGULATION OF STAT CASCADE |
19 |
144 |
0.001868 |
0.009992 |